2,000
Participants
Start Date
Not specified
Study Completion Date
October 31, 1997
Isoniazid
Pyrazinamide
Pyridoxine hydrochloride
Rifampin
Clinical Directors Network of Region II, New York
Beth Israel Med Ctr, New York
Harlem AIDS Treatment Group / Harlem Hosp Ctr, New York
Bronx Lebanon Hosp Ctr, The Bronx
Addiction Research and Treatment Corp, Brooklyn
Philadelphia FIGHT, Philadelphia
Wilmington Hosp / Med Ctr of Delaware, Wilmington
Veterans Administration Med Ctr / Regional AIDS Program, Washington D.C.
Johns Hopkins Univ / Brazil, Baltimore
Johns Hopkins Univ / School of Hygiene & Public Health, Baltimore
Richmond AIDS Consortium, Richmond
AIDS Research Consortium of Atlanta, Atlanta
Comprehensive AIDS Alliance of Detroit, Detroit
Henry Ford Hosp, Detroit
Chicago Dept of Health / Speciality STD Clinic, Chicago
AIDS Research Alliance - Chicago, Chicago
Louisiana Comm AIDS Rsch Prog / Tulane Univ Med, New Orleans
Community Consortium / UCSF, San Francisco
Denver CPCRA / Denver Public Hlth, Denver
Hill Health Corp, New Haven
Boston Dept of Health and Hosps, Boston
Southern New Jersey AIDS Cln Trials / Dept of Med, Camden
Saint Michael's Med Ctr, Newark
Lattimore Comprehensive Pulmonary Disease Clinic, Newark
North Jersey Community Research Initiative, Newark
National Institute of Allergy and Infectious Diseases (NIAID)
NIH